Unlike B12 deficiency, there is no specific treatment to reduce elevated levels, nor is this usually necessary, as high B12 is not directly toxic
"Health Canada won't approve it as a drug, but it slips through as a compounded natural health product, where the federal safety check basically doesn't happen." Health Canada considers NHP compounding within a practitioner-patient relationship distinct from manufacturing and not subject to the same regulatory oversight
When to seek medical advice: Severe pain, swelling, or signs of infection at injection sites Allergic symptoms (rash, difficulty breathing, facial swelling) Unexplained fatigue, jaundice, or dark urine Any concerning symptoms following injection Patients should always disclose use of lipotropic injections to their GP, as this information may be relevant for diagnosis and management of other conditions
High folic acid intake can also mask symptoms of vitamin B12 deficiency
Long-term safety data for BPC-157 remains limited due to its research compound status